Reveals RuP nanoparticles enable efficient C(sp3)–H deuteration in piperazine, suggesting a novel catalytic approach.
Deuterated nitrogen-containing saturated heterocycles are indispensable motifs in pharmaceuticals, yet activation of inert C(sp 3 )–H bonds in heterogeneous catalysis remains challenging because of the intrinsic chemical inertness and restricted geometric accessibility. This study demonstrates that efficient C(sp 3 )–H activation arises from a phosphorus-modulated Ru-site environment, rather than from simply favoring planar metal configurations or electronic perturbation. Phase-selective synthesis of Ru–P nanoparticles on N-doped carbon identifies RuP as a distinct phase that enables near-quantitative (99%) deuteration of piperazine C(sp 3 )–H bonds under mild conditions using D 2 as the sole deuterium source, even at a low H/D molar ratio of 1:5. KIE measurements uncover distinct kinetic signatures across the Ru–P phases, suggesting that the relative kinetic relevance of D 2 activation and C(sp 3 )–H cleavage depends strongly on the Ru-site environment. Theoretical calculations indicate that RuP nanoparticles favor exposed and isolated Ru sites, which give rise to the lowest C(sp 3 )–H activation barrier (0.47 eV), while accompanying charge density analyses further reveal an optimal-rather than maximal-degree of charge transfer that promotes N–Ru anchoring and C–H bond polarization. Collectively, these findings provide a nanoscale structure-guided framework for heterogeneous C(sp 3 )–H deuteration, enabling an efficient and practical route to deuterated saturated heterocycles through hydrogen isotope exchange.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: